Filing Details
- Accession Number:
- 0001181431-12-054537
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-11 19:56:16
- Reporting Period:
- 2012-10-10
- Filing Date:
- 2012-10-11
- Accepted Time:
- 2012-10-11 19:56:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
874015 | Isis Pharmaceuticals Inc | 2855 Gazelle Court Carlsbad CA 92010 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-10-10 | 6,299,500 | $0.00 | 6,299,500 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2012-10-10 | 750,000 | $4.00 | 7,049,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2012-10-10 | 6,299,500 | $0.00 | 6,299,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- Upon the closing of the Issuer's initial public offering, every 2 shares of Series A Preferred Stock automatically converted into 1 share of Common Stock and had no expiration date.
- The shares were purchased at the Issuer's initial public offering.